178 related articles for article (PubMed ID: 31816603)
1. Identification of differentially expressed genes in non-small cell lung cancer.
Wang K; Chen R; Feng Z; Zhu YM; Sun XX; Huang W; Chen ZN
Aging (Albany NY); 2019 Dec; 11(23):11170-11185. PubMed ID: 31816603
[TBL] [Abstract][Full Text] [Related]
2. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis.
Ma W; Wang B; Zhang Y; Wang Z; Niu D; Chen S; Zhang Z; Shen N; Han W; Zhang X; Wei R; Wang C
Cancer Cell Int; 2019; 19():239. PubMed ID: 31528121
[TBL] [Abstract][Full Text] [Related]
4. Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Xiong Y; Feng Y; Qiao T; Han Y
Cancer Biomark; 2020; 27(2):243-250. PubMed ID: 32083573
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
6. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
[TBL] [Abstract][Full Text] [Related]
7. Identidication of novel biomarkers in non-small cell lung cancer using machine learning.
Wang F; Su Q; Li C
Sci Rep; 2022 Oct; 12(1):16693. PubMed ID: 36202977
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
[TBL] [Abstract][Full Text] [Related]
9. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
10. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer.
Wang M; Li P; Wan R; Liu X
Biomed Pharmacother; 2019 Apr; 112():108590. PubMed ID: 30784913
[TBL] [Abstract][Full Text] [Related]
12. Identification of key differentially expressed genes associated with non‑small cell lung cancer by bioinformatics analyses.
Xiao Y; Feng M; Ran H; Han X; Li X
Mol Med Rep; 2018 May; 17(5):6379-6386. PubMed ID: 29532892
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
14. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Long Non-Coding RNA Expression Profiles in Non-Small Cell Lung Cancer.
Wang L; Chen Z; An L; Wang Y; Zhang Z; Guo Y; Liu C
Cell Physiol Biochem; 2016; 38(6):2389-400. PubMed ID: 27299310
[TBL] [Abstract][Full Text] [Related]
16. Prediction of response to pemetrexed in non-small-cell lung cancer with immunohistochemical phenotyping based on gene expression profiles.
Visser S; Hou J; Bezemer K; de Vogel LL; Hegmans JPJJ; Stricker BH; Philipsen S; Aerts JGJV
BMC Cancer; 2019 May; 19(1):440. PubMed ID: 31088547
[TBL] [Abstract][Full Text] [Related]
17. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of non-small-cell lung cancer microarray datasets identifies several prognostic biomarkers.
Qin X; Chen R; Xiong R; Tan Z; Gao S; Lin C; Huo T
Future Oncol; 2019 Sep; 15(27):3135-3148. PubMed ID: 31426680
[No Abstract] [Full Text] [Related]
19. The clinical and prognostic significance of YWHAZ in non-small-cell lung cancer patients: Immunohistochemical analysis.
Deng Y; Zheng J; Ma J
J Cell Biochem; 2019 Apr; 120(4):6290-6298. PubMed ID: 30378158
[TBL] [Abstract][Full Text] [Related]
20. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Feng A; Tu Z; Yin B
Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
